e-learning
resources
Berlin 2001
Monday 24.09.2001
Problems in treatment of TB
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of treatment outcomes for multidrug-resistant tuberculosis
V. Leimane, V. Skripconoka, E. Zarovska, I. Sture (Riga, Latvia)
Source:
Annual Congress 2001 - Problems in treatment of TB
Session:
Problems in treatment of TB
Session type:
Thematic Poster Session
Number:
2065
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Leimane, V. Skripconoka, E. Zarovska, I. Sture (Riga, Latvia). Evaluation of treatment outcomes for multidrug-resistant tuberculosis. Eur Respir J 2001; 16: Suppl. 31, 2065
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Predictors of treatment outcome in multidrug-resistant tuberculosis
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Management and treatment of multidrug-resistant tuberculosis
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019
Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal
Source: Eur Respir J 2013; 42: 1747-1749
Year: 2013
Long-term treatment outcomes in multidrug-resistant tuberculosis (MDR-TB)
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis
Source: Eur Respir J 2013; 42: 504-512
Year: 2013
Management of multidrug-resistant tuberculosis and patients in retreatment
Source: Eur Respir J 2005; 25: 928-936
Year: 2005
Effect of fluoroquinolones on microbiologic outcome and survival in the treatment of multidrug-resistant tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 380s
Year: 2006
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
Source: Eur Respir J 2013; 41: 1393-1400
Year: 2013
Long-term results of multidrug-resistant tuberculosis treatment.
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country
Source: Eur Respir J, 57 (6) 2002544; 10.1183/13993003.02544-2020
Year: 2021
Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis
Source: Eur Respir J, 49 (5) 1700742; 10.1183/13993003.00742-2017
Year: 2017
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis
Source: Eur Respir J , 49 (3) 1601799; DOI: 10.1183/13993003.01799-2016
Year: 2017
Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Source: Eur Respir J 2009; 33: 1085-1094
Year: 2009
Treatment outcome of multi-drug resistant tuberculosis
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004
Outcome of pulmonary multidrug-resistant tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 419s
Year: 2007
Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis
Source: Eur Respir J 2015; 46: 444-455
Year: 2015
Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003
Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004
The individual-tailored treatment regimens for multidrug-resistant tuberculosis
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept